This Drug is the Best and Worst News for Cystic Fibrosis
This CF drug is good news for health... and also awful news financially.

This Drug is the Best and Worst News for Cystic Fibrosis

Not long ago, Vertex Pharmaceuticals scored a big one for their investors—the European Commission has approved the use of ORKAMBI® (lumacaftor/ivacaftor), for the treatment of cystic fibrosis. This breakthrough treatment will be used…

Continue Reading This Drug is the Best and Worst News for Cystic Fibrosis

FH Patients Win Big In Innovative New “Pay to Perform” Deal

So here’s a nice antidote to all those stories about greedy pharma execs soaking patients for ultra-expensive treatments. There’s a new approach to contrpay-acting between insurance companies and pharmaceutical companies…

Continue Reading FH Patients Win Big In Innovative New “Pay to Perform” Deal
UVA Ph.D and One of the Longest-Living Cystic Fibrosis Survivors Inspires
Source: Patrick Neil (https://commons.wikimedia.org/wiki/User:Patrickneil)

UVA Ph.D and One of the Longest-Living Cystic Fibrosis Survivors Inspires

This month, I came across the most refreshing article written by Caroline Newman and featured in UVA Today's Art & Culture section about one of the longest living cystic fibrosis survivors.…

Continue Reading UVA Ph.D and One of the Longest-Living Cystic Fibrosis Survivors Inspires
Editor’s Choice Weekend Roundup: We’re Teaming Up with CysticLife
Editor's Choice Weekend Round Up for 12/11/2015

Editor’s Choice Weekend Roundup: We’re Teaming Up with CysticLife

Happy Friday PatientWorthians! We are so excited to announce our partnership with CysticLife this month. PatientWorthy is teaming up with CysticLife.org to spread awareness of CF and support their collaboration with the Mayo…

Continue Reading Editor’s Choice Weekend Roundup: We’re Teaming Up with CysticLife

No-Way-Cupid

I’ve been using internet dating sites for the past eleven years. I have also been dealing with a rare and undiagnosed disease for the past five and a half years.…

Continue Reading No-Way-Cupid